Clinical Trial Update: Anesthetic Efficacy of 1,8mL and 3,6mL of Articaine in Inferior Alveolar Nerve Block in Irreversible Pulpitis [NA]

View source ↗

Summary

A completed clinical trial comparing 1.8 mL vs 3.6 mL of articaine for inferior alveolar nerve block in irreversible pulpitis to assess anesthesia efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Drugs mentioned

• Articaine (articaine)

Snippet

Sponsor: Isabel Peixoto Tortamano | Conditions: Pulpitis | NA | Status: COMPLETED